Dec 17, 2021   SOURCE: BusinessWire

Global Microneedle Drug Delivery Systems Market (2021 to 2027) - Featuring Zosano Pharma, Raphas and Endoderma Among Others - ResearchAndMarkets.com

The "Global Microneedle Drug Delivery Systems Market By Type, By Material, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Microneedle Drug Delivery Systems Market size is expected to reach $9.1 billion by 2027, rising at a market growth of 7.8% CAGR during the forecast period.

Key Market Players

  • AdminMed nanoBioSciences LLC
  • Becton, Dickinson and Company
  • Zosano Pharma Corporation
  • Raphas co. ltd.
  • Nanopass Technologies Ltd.
  • Corium International, Inc. (Gurnet Point Capital)
  • Valeritas, Inc. (Zealand Pharma)
  • Nitto Denko Corporation
  • Endoderma Ltd.
  • Innoture Medical Technology Limited

The microneedle drug delivery device is designed with the arrangement of hundreds of microneedles in a small patch order to pass an ample supply of the drug to provide a needed therapeutic response.

This device helps in the direct delivery of the drug into the viable epidermis without coming in contact with blood vessels and nerve fibers that are present in the dermal layers. Silicon, carbohydrate, silica glass, polymers, and ceramic are some of the materials utilized in the manufacturing of microneedle. Generally, microneedles are hundreds of microns long and up to 1 to 50 mm wider at the tip and almost 50-300 mm at the base.

The factors accelerating the growth of the microneedle drug delivery system market are increasing the demand for a safer alternative to conventional hypodermic injections, and rising research & development initiatives.

Additionally, the microneedle drug delivery systems have excessively been adopted due to the emerging safety issues that have short and long-term implications for patients, regulators, healthcare administrators, and clinicians. As stated by the Centers for Disease Control and Prevention, an innovative patch can facilitate the administration of the vaccine to people suffering from measles and other vaccine-preventable diseases.

COVID-19 Impact Analysis

The healthcare sector was severely affected and faced numerous challenges. Except for COVID patient, all other treatments were kept on hold to minimize the possibility of viral transmission. The demand for medical devices and equipment decreased, which led to a declined demand for microneedle drug delivery systems in the market. However, as a number of patients' treatments are on hold, it is anticipated that the demand and growth of different markets is expected to increase again in the post-COVID period, including the microneedle drug delivery systems market.

Market Growth Factors:The growth in the occurrence of premature birth

The surge in the occurrence of pre-mature birth in emerging nations and the increase in malnutrition among children are expected to boost the demand for the microneedle drug delivery systems market during the forecasting period. A significant number of premature births are noted in emerging nations such as India, Indonesia, Nigeria, and the Philippines.

Additionally, the surge in the acceptance of microneedle drug delivery systems for premature infants results in better neurological growth, enhanced intrauterine nutrient deposition, and lower chances of complications, hence enhancing their possibility of survival.

Higher prevalence of different chronic diseases

Various kinds of diseases like head & neck cancer, esophageal cancer, Crohn's, ulcerative colitis, gastric cancer, and laryngeal cancer can have an impact on oral food consumption among the patients. Due to their increasing occurrence, the microneedle drug delivery systems market is expected to be propelled in the upcoming years.

In addition, the increasing number of people suffering from various pediatric diseases such as asthma, tuberculosis, leukemia, chickenpox, bronchitis, and anemia combined with the surge in the geriatric population that are more vulnerable to chronic diseases is expected to bolster the demand for microneedle drug delivery systems over the coming years.

Market Restraining Factor:Length and size of microneedles leads to severe pain

Microneedles are available in different size, length and type. The longer microneedles may lead to excessive pain during the procedure. As the microneedles are longer in length, they touch the deepest layer of skin, which causes severe pain to the patient. Thus, excessive usage of microneedles for the delivery of vaccine or drug may lead to cause severe pain to the patient, which is anticipated to decrease the demand for the microneedle drug delivery systems in the coming years.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Industry Wide Strategic Developments - Global
3.1 Partnerships, Collaborations and Agreements
3.2 Product Launches and Product Expansions
3.3 Acquisition and Mergers
3.4 Geographical Expansions
3.5 Top Winning Strategies
3.5.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.5.2 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun - 2021, Jun) Leading Players

Chapter 4. Global Microneedle Drug Delivery Systems Market by Type

Chapter 5. Global Microneedle Drug Delivery Systems Market by Application

Chapter 6. Global Microneedle Drug Delivery Systems Market by Material

Chapter 7. Global Microneedle Drug Delivery Systems Market by Region

Chapter 8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/jganha